About: Shibo Jiang

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Shibo Jiang Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher (ORCID 0000-0003-1493-6523)

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) researcher (ORCID 0000-0003-1493-6523) (en)
rdfs:label	Shibo Jiang (en) Shibo Jiang (nl) Shibo Jiang (pt) Shibo Jiang (pt-br)
skos:prefLabel	Shibo Jiang (en) Shibo Jiang (nl) Shibo Jiang (pt) Shibo Jiang (pt-br)
name	Shibo Jiang (en) Shibo Jiang (nl) Shibo Jiang (pt) Shibo Jiang (pt-br)
affiliation	wds:Q88118974-7865ab08-428d-0cc3-faf5-a5c11c01a6df wds:Q88118974-a70b1346-4242-553b-0c8c-5ad6ab67f073
affiliation	Fudan University Shanghai Medical College New York Blood Center
Scopus author ID	wds:Q88118974-995b6f93-4f10-5f33-e2f7-c2c9b61a6711
Scopus author ID	56491898300
instance of	wds:Q88118974-19459AF2-6340-4A9E-9F91-B03EDE44DC08
instance of	Homo sapiens
skos:altLabel	Jiang Shibo (en)
occupation	wds:Q88118974-8db39467-4168-4d0d-134c-3232f9536747
sex or gender	wds:Q88118974-182e7709-448f-1b15-88a0-e5478a7c162e
on focus list of Wikimedia project	wds:Q88118974-F9C4EEE1-184E-4CF4-BB01-9E084DD637D6
educated at	wds:Q88118974-1aa7a33c-43f9-99f1-9618-3e95f2a01c8a
family name	wds:Q88118974-7db637eb-4248-a6ab-c56f-d810ae50c80f
notable work	wds:Q88118974-32fb074b-4fb7-6e85-3fe1-1be629b869d5
occupation	researcher
sex or gender	male
on focus list of Wikimedia project	WikiProject COVID-19
educated at	The Rockefeller University
family name	Jiang
notable work	Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
ORCID iD	wds:Q88118974-98238D00-E3D8-4B88-9747-23166215BA07
ORCID iD	https://orcid.org/0000-0003-1493-6523
ORCID iD	0000-0003-1493-6523
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q88118974
is author of	CL-385319 inhibits H5N1 avian influenza A virus infection by blocking viral entry Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide Receptor-binding domain as a target for developing SARS vaccines. Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity The spike protein of SARS-CoV--a target for vaccine and therapeutic development Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC. Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure. Advancements in the development of subunit influenza vaccines L-selectin and P-selectin are novel biomarkers of cervicovaginal inflammation for preclinical mucosal safety assessment of anti-HIV-1 microbicide Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection Identification of the HIV-1 gp41 core-binding motif--HXXNPF. The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion XTT formazan widely used to detect cell viability inhibits HIV type 1 infection in vitro by targeting gp41. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity θ-Defensins Prevent HIV-1 Env-mediated Fusion by Binding gp41 and Blocking 6-Helix Bundle Formation Efficacy, stability, and biosafety of sifuvirtide gel as a microbicide candidate against HIV-1 Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitor Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41 ADS-J1 inhibits human immunodeficiency virus type 1 entry by interacting with the gp41 pocket region and blocking fusion-active gp41 core formation Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitors Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines. Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus Mapping of antigenic sites on the nucleocapsid protein of the severe acute respiratory syndrome coronavirus Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software